BlackRock Health Sciences Trust (BME) — Cash Flow Reinvestment Rate

Latest as of June 2025: 0.00x

BlackRock Health Sciences Trust (BME) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $5.09 Million. See BME free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

$0.00
Capex + Investments

Operating Cash Flow

$5.09 Million
USD

Capital Expenditures

$0.00
USD

BlackRock Health Sciences Trust Cash Flow Reinvestment Rate (2006–2024)

Historical reinvestment intensity for BlackRock Health Sciences Trust across 10 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of BlackRock Health Sciences Trust.

Annual Cash Flow Reinvestment Rate for BlackRock Health Sciences Trust (2006–2024)

Year-by-year capital reinvestment analysis for BlackRock Health Sciences Trust. See BME free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2024 0.00x $0.00 $65.52 Million $0.00 ▼ -100.0%
2023 0.00x $3.00 $32.02 Million $3.00
2018 0.00x $0.00 $2.05 Million $0.00
2016 0.00x $0.00 $2.01 Million $0.00
2015 0.00x $0.00 $1.28 Million $0.00
2014 0.00x $0.00 $115.30 Million $0.00
2013 0.00x $0.00 $17.57 Million $0.00
2012 0.00x $0.00 $16.44 Million $0.00
2007 0.00x $0.00 $36.61 Million $0.00
2006 0.00x $0.00 $24.58 Million $0.00
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow